Get Adobe Flash player
Special Report The European Association for the Study of Diabetes – Bringing Research, Education and Funding Together Viktor Jörgens 1 and Monika Grüsser 2 1. Executive Director; 2.Vice Director, European Association for the Study of Diabetes, Düsseldorf, Germany Disclosure: The authors are employees of the European Association for the Study of Diabetes and have no other conflicts of interest to declare. Received: 22 May 2013 Accepted: 29 May 2013 Citation: European Endocrinology, 2013;9(2):74–5 Correspondence: Viktor Jörgens, European Association for the Study of Diabetes, Rheindorfer Weg 3, 40591 Düsseldorf, Germany. E: secretariat@easd.org In 1965 the first General Assembly of the European Association for the Study of Diabetes (EASD) was held with Dr AE Renold and 220 participants in Montecatini, Italy. The decision to form the EASD was taken in the preceding year at the International Diabetes Federation (IDF) Congress in Toronto. Dr Renold presented the Statutes, which have been left virtually unchanged to today, and they were unanimously adopted. The establishment of Diabetologia was announced, with Dr K Oberdisse as the first Editor-in-Chief. Five honorary members were also elected: Prof CH Best, Sir H Dale, Dr RD Lawrence, Prof BA Houssay and Dr HC Hagedorn. Dr Renold also announced the creation of the Minkowski Lectureship, which is today one of the most prestigious prizes in the diabetes field. Dr F Hoet was elected President and the newly elected Council included Drs Renold, JG Alivisatos, R Luft, K Lundbaek, EF Pfeiffer and FG Young – a prestigious list to say the least. • • • • • • • • • • The first annual meeting took place at the same time, with papers in French, German and English being presented – it was not until 1970– 1971 that English was adopted as the single language of the EASD. The list of authors of these first presentations makes interesting reading. They include EF Pfeiffer, WJH Butterfield, JP Felber, W Malaisse, LG  Heding, R Korec, PH Sönksen, ER Froesch, J Pirart, W Creutzfeldt, A  Czyzyk, Z Skrabalo, R Oesterby and H Keen. Back then there were only 48 submissions, a far cry from the 2,300+ abstracts now received each year. Postgraduate education is a major focus of the EASD and, to date, EASD has organised courses in Africa, Asia, South America, Europe and the Middle East. Bringing experts to developing areas of the globe to share information, techniques and to answer questions has proven to be an extremely popular and highly rewarding experience for all involved. Today, the EASD has moved into an era of technology and mass internet communication. The development of the EASD Virtual Meeting gives all interested parties the opportunity to view world-class presentations on the newest advances in diabetes research and treatments. They can been viewed for free on the internet and through SmartPhone Apps. The mission of the EASD is to promote excellence in diabetes care through research and education – a mission we strive to achieve with our free access to information and postgraduate courses worldwide. Our annual meeting now brings together over 18,000 delegates from all over the world each year to learn, communicate, interact and build new, or solidify, long-standing friendships and collaborations, which are evident with the official Study Groups of the EASD. These are groups of researchers working, meeting, sharing ideas and striving for answers together. The current Study Groups are: • • 74 Artificial Insulin Delivery System (AIDPIT); Diabetes Education Study Group (DESG); • • • Diabetic Pregnancy Study Group (DPSG); Diabetes Neuropathy Study Group (NEURODIAB); EASD Eye Complication Study Group (EASDEC); European Diabetic Nephropathy Study Group (EDNSG); EASD Islet Study Group; European Diabetes Epidemiology Group (EDEG); Diabetes and Nutrition Study Group (DNSG); Psychosocial Aspects of Diabetes (PSAD); Diabetic Foot Study Group (DFSG); EASD Study Group on Primary Care Research in Diabetology (PCD); Diabetes Economic and Care Delivery (DECADE); Genetics of Diabetes Study Group (SGGD); and Diabetes and Cardiovascular Disease Study Group (D&CVD). EASD is proud to be playing a major role in the development and advancement of diabetes management and treatments in areas where there is not only a need for such information, but also an enthusiastic audience, eager to learn and gain knowledge. But there was also a need to support and encourage research and, in 1999, the EASD increased its commitment to stimulate diabetes research in Europe by creating the European Foundation for the Study of Diabetes (EFSD). The Foundation is closely related to the EASD; it is governed exclusively by the Executive Committee of the EASD, which itself is under the close supervision of the EASD Council and the General Assembly of the EASD. The EFSD and EASD operate on a strictly non-profit basis under the control of the relevant authorities for charity and taxation in order to support diabetes research. In order to advance diabetes research at the highest level in Europe, EFSD has entered into innovative partnerships with other foundations and with industry. To date, it has committed more than €88,000,000 1 to diabetes research in Europe by various funding means. EFSD runs numerous basic and clinical research programmes focusing on topics ranging from the role of the kidney in diabetes to patient education. © Touch ME d ica l ME d ia 2013